Clinical trial
Efficacy, Safety, & Pharmacokinetics of Candesartan Cilexetil in Hypertensive…
NCT00244595 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00244595 |
|---|---|
| Title | Efficacy, Safety, & Pharmacokinetics of Candesartan Cilexetil in Hypertensive Paediatric Subjects 6 to < 17 Years of Age |
| Official title | A Multicenter, Multinational, Open-Label Study of the Efficacy, Safety, and Pharmacokinetics of Candesartan Cilexetil in Hypertensive Paediatric Subjects 6 to < 17 Years of Age |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | candsartan cilexetil |
| Enrollment | 235 |
| Start date | Sep 1, 2003 |
| Completion | Nov 1, 2006 |
| First posted | Oct 27, 2005 |
| Last update posted | Dec 9, 2009 |
| Countries | Belgium, Hungary, Slovakia, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: